Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Lamia Hamdi

Showing results (1-10 of 3) with videos related to

Pageof 1
Sort By:
La Tunisie Medicale|June 3, 2005
[Pathomimia in upper limb]Riadh Maalla, Hichem Bensalma, Lamia Hamdi, et al.
Clinical and Experimental Gastroenterology|November 15, 2018
A study of the circulating fibroblast growth factor 21 as a novel noninvasive biomarker of hepatic injury in genotype-4 chronic hepatitis C: Egyptian patients and their response to direct-acting antiviral agentsGhada M El Sagheer, Asmaa K Ahmad, Aliaa S Abd-ElFattah, et al.
Pharmacogenomics|October 9, 2024
Effects of genetic and clinical factors on thiopurine drugs pharmacokinetics in Tunisian patientsZohra Chadli, Ibtissem Hannachi, Manel Ben Belgacem, et al.
Pageof 1

Showing results (1-10 of 3) with videos related to

Sort By:
Pageof 1
La Tunisie Medicale|June 3, 2005
[Pathomimia in upper limb]Riadh Maalla, Hichem Bensalma, Lamia Hamdi, et al.
Clinical and Experimental Gastroenterology|November 15, 2018
A study of the circulating fibroblast growth factor 21 as a novel noninvasive biomarker of hepatic injury in genotype-4 chronic hepatitis C: Egyptian patients and their response to direct-acting antiviral agentsGhada M El Sagheer, Asmaa K Ahmad, Aliaa S Abd-ElFattah, et al.
Pharmacogenomics|October 9, 2024
Effects of genetic and clinical factors on thiopurine drugs pharmacokinetics in Tunisian patientsZohra Chadli, Ibtissem Hannachi, Manel Ben Belgacem, et al.
Pageof 1